Dr. Graff obtained her master’s degree in Immunology from Loyola University in Chicago and earned her Doctor of Osteopathic Medicine credentials from Lake Erie College of Osteopathic Medicine in Bradenton, Florida in 2009. 

She completed her residency training in Internal Medicine and a fellowship in Hematology and Oncology at the Medical College of Wisconsin at Froedtert Memorial Lutheran Hospital. She has led several clinical research projects and has published many original oncology and hematology articles. Dr. Graff is board certified in both Internal Medicine and Medical Oncology.

Dr. Graff has worked at Mission Cancer and Blood in Des Moines IA for the over 9 years specializing in CLL and NHL. 

Dr. Graff serves on the BMS National CAR-T Cell Advisory Board for Lymphoma as well as sitting on multiple National Lymphoma Advisory Boards, NHL Advisory Council and LBCL Steering Committee. She is a member of ECOG Clinical Trial Organization, Lymphoma Working Committee for the CIBMTR and sits on the Lymphoma Research Foundation (LRF).  She has paired with LLS doing patient education for rural cancer patients as well as CAR-T and bispecific education for community oncologists.  Dr. Graff is the cellular therapy lead for Exigent Research as well as co-chair for the malignant hematology council for Exigent Research.  She is an educational speaker for many companies and is trained in MRD interpretation through Adaptive Biotech.

Dr. Graff serves as the Primary Investigator for multiple clinical trials both past and present and is Physician Champion and Lead for Mission Cancer and Blood Clinical Trials Program. 

She is the recipient of the 2023 Q2 Targeted Oncology ICONS Award and has been Nominated for Visionary of the Year by the leukemia and lymphoma society for 2024.